-
The FDA has approved a new drug with a novel mechanism of action for the treatment of rheumatoid arthritis in patients intolerant to or who have had inadequate response to methotrexate. Tofacifinib is an oral Janus kinase (JAK) inhibitor and is marketed by Pfizer as Xeljanz.
-
In this small pilot study of patients who sought help for insomnia, most of the awakenings were actually caused by sleep-disordered breathing.
-
-
-
Use of dexamethasone in community-acquired bacterial meningitis is associated with long-term survival in treated patients.
-
Advantages of a rapid response team extended beyond a reduction in codes to impact multiple endpoints, including positive effects on nurse morale and empowerment, unit workload, and education.
-
Angioedema is an infrequent, but serious, adverse event from drug therapy. Drugs that affect the renin-angiotensin-aldosterone system have been linked to angioedema, but the relative frequency of this complication with these drugs is poorly understood.
-
This study shows that as hospitals adopt electronic workflows, automatic triggering of a rapid response system based solely on changes in vital signs could place a tremendous burden on the system.
-
In a meta-analysis, investigators found that recent studies show no difference in the risk of catheter-related bloodstream infections between internal jugular, subclavian, and femoral sites. Older studies had a lower risk for the internal jugular site compared to the femoral site.
-
The ECG shown above was obtained from a 74-year-old woman who presented with abrupt onset of severe renal colic but no chest pain. Based on findings seen in her ECG, acute cardiac catheterization was performed. Her coronary arteries were normal on cath.